C. Evan Ballantyne

2015 - Synthetic Biologics

In 2015, C. Evan Ballantyne earned a total compensation of $716.2K as Former Chief Financial Officer at Synthetic Biologics, a 16% decrease compared to previous year.

Compensation breakdown

Option Awards$297,167
Salary$124,356
Other$294,711
Total$716,234

Ballantyne received $297.2K in option awards, accounting for 41% of the total pay in 2015.

Ballantyne also received $124.4K in salary and $294.7K in other compensation.

Rankings

In 2015, C. Evan Ballantyne's compensation ranked 9,440th out of 13,638 executives tracked by ExecPay. In other words, Ballantyne earned more than 30.8% of executives.

ClassificationRankingPercentile
All
9,440
out of 13,638
31st
Division
Manufacturing
3,596
out of 5,190
31st
Major group
Chemicals And Allied Products
1,311
out of 1,854
29th
Industry group
Drugs
1,069
out of 1,528
30th
Industry
Pharmaceutical Preparations
835
out of 1,182
29th
Source: SEC filing on July 6, 2016.

Ballantyne's colleagues

We found two more compensation records of executives who worked with C. Evan Ballantyne at Synthetic Biologics in 2015.

2015

Jeffrey Riley

Synthetic Biologics

Chief Executive Officer

2015

Steven Shallcross

Synthetic Biologics

Chief Financial Officer

You may also like